基本信息
浏览量:47
职业迁徙
个人简介
Freddy’s research areas are in functional biomaterials for medical devices, nanomaterials and nanostructures for cell regeneration. He has developed 118 patents and founded several companies to commercialize his cardiovascular, ocular and surgical implants. His customizable hernia mesh has received US and China FDA approvals and received US & China funding as a US company. His fully biodegradable heart stent company, Amaranth, has been substantially funded by a Silicon Valley VC, EDB and the top US Medical Device company, Boston Scientific, for a series of advanced US FDA clinical trials in several hundred patients worldwide. His most recent company, Peregrine, is based on a nano based drug delivery system to treat Glaucoma, which has been successfully deployed in human trials. He has published over 361 top journal papers with a citation of 18,000 and H-Index of 62.
研究兴趣
论文共 332 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
semanticscholar(2019)
引用0浏览0引用
0
0
CRC Press eBookspp.303-383, (2017)
Carbon Nanomaterials Based on Graphene Nanosheetspp.384-494, (2017)
Carbon Nanomaterials Based on Graphene Nanosheetspp.495-588, (2017)
Acta Biomaterialia (2017): 220-233
加载更多
作者统计
#Papers: 333
#Citation: 32421
H-Index: 82
G-Index: 174
Sociability: 7
Diversity: 4
Activity: 6
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn